Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Stockwatch: Limited Acquisition Headroom At Specialty Pharma

Feb 20 2017

• By Andy Smith

Stockwatch_1200x675 — Andy Smith gives a life sciences investor's perspective on biopharma business

Related Content

Shire's Record Year Bolstered By Baxalta, But Shows Across-The-Board Growth

Feb 17 2017

Teva CEO Steps Down While An Integration Hangs In The Balance

Feb 08 2017

Allergan Confident About Continued Growth, Swats Down Competition Concerns

Feb 09 2017

Teva Undertaking Strategic Review As It Searches For New CEO

Feb 13 2017

PTO Affirms Shire’s Lialda Patent; First Decision In Kyle Bass IPR Case

Oct 07 2016

Related Companies

Teva Pharmaceutical Industries Ltd.

Allergan plc

Takeda Pharmaceutical Co. Ltd.

Baxalta Incorporated

Allergan plc

Anda, Inc.

Bristol Myers Squibb Company

ZELTIQ Aesthetics, Inc.

Allergan, Inc.

Novartis AG

Additional Topics

M & A Sales & Earnings Business Strategies Commercial Strategy BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window